virology, immunology and gardening. Views are my own. #Influenza #SARSCoV2 #herpes #respiratory #MCF
wirral
Joined February 2011
- Tweets364
- Following129
- Followers440
- Likes317
Great to see our new preprint out and first MS from PhD student Dan Mega. Highlights #antiviral use and MOA of a novel phlorotannin rich purified extract from seaweed against #influenza . Great #livuniives #livuninews biorxiv.org/content/10.1101/…
Great to be in Japan 🇯🇵 presenting our latest #Covid_19 data at the @jsv1953 Japanese Society for Virology meeting. @LivUni_IVES @livuninews Such welcoming hosts
Saturday high tide, sunset and surf at beautiful peaceful Cemaes bay @CemaesB @TonyaTemplar #cemaesbayswimmers #Anglesey
James Stewart 🦠🌿 retweeted
Huge thank you to all teams that took part in this study: @Bicycle_tx @molvirol @_AndrewOwen_ @HyvonenGroup and members of @JamesLab9 group Marina Vaysburd (twiterless), @AnnaAlbecka @guipap_ and @donna_mallery
James Stewart 🦠🌿 retweeted
Exciting new study from the lab published today! Excellent collaboration between @Bicycle_tx and academic labs to characterise new antiviral modality against #SARSCoV2 : Bicycle #antiviral #COVID19 #Spike
rdcu.be/deGq1
James Stewart 🦠🌿 retweeted
An off-patent liver disease drug could prevent #COVID19 infection, a new @Nature study has found.
@livuniHLS scientists played a key role in the collaborative study, which involved a unique mix of ‘mini-organs’, donor organs, animal studies & patients.
news.liverpool.ac.uk/2022/12…
James Stewart 🦠🌿 retweeted
This important work was a brilliant collaborative effort led by University of Cambridge.
The work undertaken by CELT scientists was a joint effort between @molvirol and @CELT_pharm.
Congratulations to everyone involved. @_AndrewOwen_ @molvirol @LivUniISMIB
#covid19
Great to be part of this study describing the potential of an approved, inexpensive, off-patent drug for liver disease in combatting Covid infections @LivUni_IVES @livuninews @CELTLiverpool @uk_icn #SARSCoV2 nature.com/articles/s41586-0…
James Stewart 🦠🌿 retweeted
Just published @Nature
An approved, inexpensive, off-patent drug for liver disease, UDCA, an FXR blocker, has supportive data in organoids, experimental models, and people for blocking Covid infections and/or reducing its severity nature.com/articles/s41586-0…
Our review on the role of non-canonical autophagy in control of infection published today @LivUni_IVES @livuninews @TheQuadram #influenza science.org/doi/10.1126/scia…
Fab display this AM from Bedminster Down. #BristolBalloonFiesta #BristolBalloon sheep followed by a wolf 😎
James Stewart 🦠🌿 retweeted
5 Studies, 5 Figures. All consistent, independent replications in vivo, in vitro. Omicron can't infect lungs or lung cells as well as prior variants.
@KU_Leuven @SystemsVirology @GuptaR_lab @hkumed @LivUni
James Stewart 🦠🌿 retweeted
With yet another in vivo study of Omicron infection today, it sure is looking that this variant has less virulence, less chance of inducing Covid pneumonia👍
New report: biorxiv.org/content/10.1101/…
Added to our immunity wall and T cell defense, this is all good.
James Stewart 🦠🌿 retweeted
New data from our amazing team showing Omicron produces less severe disease than Pango B and Delta SARS-CoV-2 variants in a mouse model 🐭 biorxiv.org/content/10.1101/…
Our Preprint now published. SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19 biorxiv.org/content/10.1101/… @molvirol #omicron #SARSCoV2 @_andrewowen
James Stewart 🦠🌿 retweeted
We @NeytsVirology show omicron #SARSco2 does not readily infect lungs of hamsters (contrast to other strains). Reasons may be 1) too well adapted to man 2) infects rather the upper respiratory tract 3) is less pathogenic or, combination of above. biorxiv.org/content/10.1101/…